Program & Project Management Leader
- Regular/Permanent
- USA / Massachusetts
- Remote Options
Welcome to Orano
Helping to meet current and future challenges to preserve our world and build the world of tomorrow while taking care of everyone's health is stimulating for you. For us too. By joining the Orano Group, a leading international player in the nuclear industry, you are in the right place.
Every day we work to produce efficient low-carbon energy, to fight global warming, to find solutions that save natural resources, and to contribute to progress in health.
Our strengths? Across the entire fuel cycle, we have extensive expertise in cutting-edge technologies, safe, high value-added products and services, and a strong capacity for innovation. All of these factors reflect the strong skills of our 17,000 employees, whom we are constantly striving to develop. With their different backgrounds and experience, they are proof of our openness to all talents. They share the same ambition: to give nuclear energy its full value.
Every day we work to produce efficient low-carbon energy, to fight global warming, to find solutions that save natural resources, and to contribute to progress in health.
Our strengths? Across the entire fuel cycle, we have extensive expertise in cutting-edge technologies, safe, high value-added products and services, and a strong capacity for innovation. All of these factors reflect the strong skills of our 17,000 employees, whom we are constantly striving to develop. With their different backgrounds and experience, they are proof of our openness to all talents. They share the same ambition: to give nuclear energy its full value.
Job description
The Program & Project Management Leader (PPML) is a senior drug development leader with exceptional strategic and collaborative skills. This individual will directly lead one or more development program(s). In addition, this newly created role at Orano Med will also establish the key processes and tools in order to establish a fit for purpose function in order to support the rapid expansion of our pipeline of future cancer medicines based on our leading Pb212-based alpha therapy platform.
Primary Responsibilities:
- Acts as the cross-functional leader accountable for leading the design, approval and delivery of the integrated drug program strategy for our most advanced program, currently finishing phase 2. The role may also include future programs, from first-in-human study throughout the lifecycle, hence maximizing the value of the asset/program(s) or group of programs, consistent with the company strategy.
- Leads a high performing, cross-functional Global Development Team (GDT) composed of subject matter experts from the various functions contributing to the drug development process (research, translational, regulatory, clinical, manufacturing, medical affairs, IP, communication, quality, compliance and commercial).
- In addition, as some assets will be partnered with external collaborators, the PPML will have to collaborate with external parties, both biotech and larger pharmaceutical companies.
- Leads GDT meetings, ensure cross functional alignment, positive dynamics and productivity.
- Accountable to ensure there is a sound, competitive and compelling, asset strategy and execution plan to ultimately achieve global regulatory filings and ensure wide access of the compound.
- Accountable for the execution and delivery of strategic plans with speed, agility and high-quality. Ensuring that innovative as well as practical approaches are used to design development plans.
- Maintaining the highest degree of integrity and ethics, a drive for performance and differentiation.
- Managing development budget to ensure planning and spending is within approved budgets and consistent with established operating expense goals and in line with Orano Med processes.
- Providing proactively regular strategic and tactical status updates to management and governance on progress, risks, opportunities and challenges, and pertinent changes in the external environment
- Responsible for establishing this new role at Orano Med and creating core program management processes accordingly.
- Direct oversight for the project management function, also being newly established.
Our Full-Time Benefits
- Competitive compensation
- Health, Dental, and Vision insurance – with generous employer contributions
- 401(k) with employer matching and contribution amounts
- Life insurance and Short- and Long-Term Disability insurance provided by the company
- Generous Paid Time Off and holiday schedules
- Numerous Training and Development opportunities
- and more…
Ideal qualifications
All candidates must meet the following minimum requirements in order to be considered for this opportunity:
- Advanced science degree (PharmD, PhD or equivalent degree+) or MBA with more than 7 years in pharmaceutical industry as a program lead.
- Proven late-stage experience drug development experience in the field of oncology/hematology. Additional early-stage experience is a plus.
- Previous experience in mid-size pharma or biotech is a plus.
- Ability to thrive in fast-paced, agile and high-growth biotech environment.
- Exceptional communication, collaboration and cross-functional skills, both written and verbal.
- Experience with alliances and external collaboration.
- Business and financial acumen.
- Experience of working in an international environment.
- Demonstrated ability to drive initiatives, solve issues, pre-empt problems and achieve objectives.
- Ability to resolve issues/ conflict in a constructive manner.
- Ability to develop bold ideas and take calculated risks.
- Strong tolerance for ambiguity, agility to adapt to change, confidence to speak-up and challenge appropriately.
***Targeting remote workers on the East Coast.
Orano is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, national origin, age, disability, citizenship, veteran status, marital status, sexual orientation, gender identity, genetic predisposition or carrier status or any other characteristic protected by law.
Orano Med
Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells. With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.
Find out more about Orano Med
Find out more about Orano Med
